Tetra Tech (TTEK) Q3 2026 Earnings Call Transcript

Tetra Tech reported Q3 net revenue of $1.1B and adjusted EPS of $0.42, both above the top end of management guidance, supported by improved margins and working capital. Backlog rose 5% sequentially to a record ~$4.5B, while operating cash flow hit $229M for the quarter and $467M year-to-date (all-time high for the first nine months). The company raised FY2026 guidance (net revenue to $4.315B–$4.365B, adj. EPS to $1.56–$1.59) and continues returning capital with $100M Q3 buybacks and an 11% dividend increase; net debt/EBITDA fell to 0.88x from 0.96x a year ago.

Analysis

The market should treat this as a quality-of-revenue story, not just a beat-and-raise. TTEK is increasingly selling front-end technical work with funded visibility, which tends to convert into margin and cash flow faster than the broader engineering/services group; that matters because it supports a higher multiple even if top-line growth moderates. The NSR disclosure is the key tell: reported margins still understate underlying economics, so investors anchoring on headline segment margins may be missing another leg of re-rating.

Second-order, the winners are the businesses tied to water regulation, PFAS remediation, hydropower, and data-center power/water feasibility; the losers are lower-discipline peers that still depend on discretionary renewables or unfunded task orders. If federal contracting offices remain slow, that hurts near-term revenue recognition across the space, but TTEK’s conservative backlog definition and strong working-capital metrics mean it should convert better than peers with looser order quality. The real competitive edge is that AI helps throughput on bespoke design, while commoditized downstream engineering is the part most exposed to substitution.

The catalyst path is 1-3 months: guidance follow-through, backlog conversion, and whether commercial wins in data centers/PFAS offset the renewables drag. Over 6-18 months, the debate shifts to whether 50 bps annual margin improvement is actually conservative and whether the market should value TTEK more like a cash compounder than a cyclical consultant. Falsifiers: backlog growth stalls, DSO drifts back above 60, or FY27 commentary shows margin expansion reverting to low end of the historical range.

Key Decisions for Investors

• Go long TTEK on any post-earnings pullback; target a 1-3 month re-rating trade with downside defined by a failure of backlog to grow sequentially again next quarter.
• Pair trade: long TTEK / short a lower-quality engineering-services peer basket (e.g., J, ACM) to express the view that funded water/PFAS mix deserves a premium over more cyclical government/commercial exposure.
• For event-driven accounts, buy 2-3 month TTEK call spreads if the stock has not yet fully priced the guide raise; thesis breaks if next quarter’s backlog or EPS guidance is merely flat.
• Watch item, not immediate trade: if federal task-order bottlenecks ease, TTEK’s revenue conversion could accelerate materially; if they worsen, use that as an opportunity to buy only after confirmation that margins hold.
• Add a margin-thesis stop: if FY27 commentary implies margin expansion below ~50 bps or cash conversion deteriorates, reduce the long as the multiple thesis weakens.